Nanalysis Scientific (CVE:NSCI) Sets New 52-Week Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) shares hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.27 and last traded at C$0.27, with a volume of 118690 shares traded. The stock had previously closed at C$0.28.

Nanalysis Scientific Trading Down 3.4 %

The company has a 50 day simple moving average of C$0.35 and a two-hundred day simple moving average of C$0.39. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The firm has a market cap of C$31.66 million, a PE ratio of -2.42 and a beta of 0.72.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Recommended Stories

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.